Source: Annual Congress 2012 - Diagnostics in OSA: from polygraphy to genetics and cancer
Disease area: Sleep and breathing disorders, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
I. Almendros, J.M. Montserrat, M. Torres, M. Dalmases, J. Ramirez, F. Campos-Rodríguez, D. Navajas, R. Farré (Barcelona, Sevilla, Spain). Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Eur Respir J 2012; 40: Suppl. 56, 190

Member's Comments

No comment yet.

Related content which might interest you: Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea Source: Eur Respir J 2012; 39: 215-217 Year: 2012 Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea Source: Eur Respir J 2011; 39: 215-217 Year: 2012 Chronic intermittent hypoxia mimicking sleep apnoea increases spontaneous tumorigenesis in mice Source: Eur Respir J , 49 (2) 1602111; DOI: 10.1183/13993003.02111-2016 Year: 2017 Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea Source: Eur Respir J, 51 (3) 1701885; 10.1183/13993003.01885-2017 Year: 2018 Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients Source: Eur Respir J, 53 (2) 1801298; 10.1183/13993003.01298-2018 Year: 2019 Aged mice obstructive sleep apnoea model with spontaneous tumorigenesis: physiological parameters Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017 Inspiratory neural drive response to hypoxia adequately estimates peripheral chemosensitivity in OSAHS patients Source: Eur Respir J 2002; 20: 724-732 Year: 2002 Sleep disordered breathing and nocturnal hypoxemia are associated with an increased risk of lung cancer. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009 Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Chronic intermittent hypoxia reduces progressive sperm motility in a mouse model of obstructive sleep apnea Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 Recurrent airway obstructions increase circulating mesenchymal stem cells in an acute rat model of sleep apnea Source: Annual Congress 2008 - Pathogenesis of obstructive sleep apnoea Year: 2008 Prevalence of day-time hypercapnia or hypoxia in patients with OSAS and normal lung function Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Intermittent hypoxia in sleep apnea: a cause of inflammatory activation Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 Sleep apnoea in interstitial lung disease Source: Sleep and Breathing Conference 2017 Year: 2017 CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008 Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Relationship between sleep apnoea and cancer Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021 The role of angiogenesis in obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005